METHODS AND MATERIALS FOR ASSESSING RESPONSE TO PLASMABLAST- AND PLASMA CELL-DEPLETING THERAPIES
Application
US20260078199A1
Kind: A1
Mar 19, 2026
Inventors
Glennda Smithson, Jose Estevam, Nicholas Jones
Abstract
The present disclosure relates to anti-CD38 antibodies and their use as therapeutics and diagnostics. The present disclosure further relates to methods of treating autoimmune diseases, such as systemic lupus erythematosus and rheumatoid arthritis. The present disclosure further relates to diagnostic assay methods for identifying patients having autoimmune diseases for treatment.
CPC Classifications
C07K 16/2896
A61P 19/02
G01N 33/56966
A61K 2039/505
C07K 2317/21
C07K 2317/732
C07K 2317/734
G01N 2333/91148
Filing Date
2025-07-14
Application No.
19268865